SE: Carcinogens Get Into the Generic U.S. Drug Supply

Bloomberg Markets & Finance via Youtube


Sep.12 — In July 2018, the FDA announced that N-Nitrosodimethylamine, or NDMA, had been found in the widely used blood-pressure medicine valsartan and started overseeing a recall of drugs from three companies. The recall has since been expanded 51 times, to include two related drugs, irbesartan and losartan, made by at least 10 companies—some since 2014. Drugs sold to millions of people in 30 countries could be tainted. Bloomberg’s Anna Edney has more on “Bloomberg Markets: The Close.”

READ ALSO  SE: How Will Big Tech Firms Deal With New Hong Kong Security Law?